Document ID: chunk:federal_register_of_legislation:C2018A00007:clause:2_23:p2
Version: federal_register_of_legislation:C2018A00007
Segment Type: clause
Provision Reference: sch 2 cl 23 (pt 2/2)
Character Range: 39888–41051

to be listed, by force of this subitem immediately after the application lapses.
(8) Paragraph 26A(1)(e) of the Act does not apply to an application for the listing of a medicine under section 26A of the Act if the medicine had its listing cancelled only because of the operation of subitem (6) or (7).
(9) Paragraph 26AB(1)(f) of the Act does not apply to an application for the listing of a medicine under section 26AE of the Act if the medicine had its listing cancelled only because of the operation of subitem (6) or (7).

Cancellation of listing under section 26A if application under section 26AE made but not decided during transition period
(10) Subitem (11) applies if an application for the listing of the medicine in relation to the person under section 26AE of the Act that complies with section 23C of the Act has been made, but not yet decided, during the transition period.
(11) The listing of the medicine under section 26A of the Act is cancelled, and the medicine ceases to be listed under that section, by force of this subitem at the same time as the Secretary makes a decision under subsection 26AE(3) of the Act in relation to the medicine.